Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1530/EDM-21-0071

http://scihub22266oqcxt.onion/10.1530/EDM-21-0071
suck pdf from google scholar
34877930!8686175!34877930
unlimited free pdf from europmc34877930    free
PDF from PMC    free
html from PMC    free
PDF vom PMID34877930 :   free

suck abstract from ncbi

pmid34877930
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Synergistic cortisol suppression by ketoconazole-osilodrostat combination therapy #MMPMID34877930
  • Amodru V; Brue T; Castinetti F
  • Endocrinol Diabetes Metab Case Rep 2021[Dec]; 2021 (ä): ä PMID34877930show ga
  • SUMMARY: Here, we describe a case of a patient presenting with adrenocorticotrophic hormone-independent Cushing's syndrome in a context of primary bilateral macronodular adrenocortical hyperplasia. While initial levels of cortisol were not very high, we could not manage to control hypercortisolism with ketoconazole monotherapy, and could not increase the dose due to side effects. The same result was observed with another steroidogenesis inhibitor, osilodrostat. The patient was finally successfully treated with a well-tolerated synergitic combination of ketoconazole and osilodrostat. We believe this case provides timely and original insights to physicians, who should be aware that this strategy could be considered for any patients with uncontrolled hypercortisolism and delayed or unsuccessful surgery, especially in the context of the COVID-19 pandemic. LEARNING POINTS: Ketoconazole-osilodrostat combination therapy appears to be a safe, efficient and well-tolerated strategy to supress cortisol levels in Cushing syndrome. Ketoconazole and osilodrostat appear to act in a synergistic manner. This strategy could be considered for any patient with uncontrolled hypercortisolism and delayed or unsuccessful surgery, especially in the context of the COVID-19 pandemic. Considering the current cost of newly-released drugs, such a strategy could lower the financial costs for patients and/or society.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    ä ä.2021 2021